Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Strong cytoplasmic ETV1 expression has a negative impact on prostate cancer outcome.
Segalés L, Juanpere N, Lorenzo M, Albero-González R, Fumadó L, Cecchini L, Bellmunt J, Lloreta-Trull J, Hernández-Llodrà S. Segalés L, et al. Among authors: hernandez llodra s. Virchows Arch. 2019 Oct;475(4):457-466. doi: 10.1007/s00428-019-02573-1. Epub 2019 Apr 23. Virchows Arch. 2019. PMID: 31016435
ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression.
Hernández-Llodrà S, Juanpere N, de Muga S, Lorenzo M, Gil J, Font-Tello A, Agell L, Albero-González R, Segalés L, Merino J, Serrano L, Fumadó L, Cecchini L, Lloreta-Trull J. Hernández-Llodrà S, et al. Oncotarget. 2017 May 26;8(43):74106-74118. doi: 10.18632/oncotarget.18266. eCollection 2017 Sep 26. Oncotarget. 2017. PMID: 29088771 Free PMC article.
Immunohistochemical expression of mismatch repair proteins (MSH2, MSH6, MLH1, and PMS2) in prostate cancer: correlation with grade groups (WHO 2016) and ERG and PTEN status.
Albero-González R, Hernández-Llodrà S, Juanpere N, Lorenzo M, Lloret A, Segalés L, Duran X, Fumadó L, Cecchini L, Lloreta-Trull J. Albero-González R, et al. Among authors: hernandez llodra s. Virchows Arch. 2019 Aug;475(2):223-231. doi: 10.1007/s00428-019-02591-z. Epub 2019 Jun 17. Virchows Arch. 2019. PMID: 31209634
Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer.
Bowden M, Nadal R, Zhou CW, Werner L, Barletta J, Juanpere N, Lloreta J, Hernandez-Llodrà S, Morote J, de Torres I, Orsola A, Cejas P, Long H, Bellmunt J. Bowden M, et al. Among authors: hernandez llodra s. Sci Rep. 2020 Nov 18;10(1):20135. doi: 10.1038/s41598-020-76904-7. Sci Rep. 2020. PMID: 33208770 Free PMC article.
Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer.
Segalés L, Juanpere N, Gallarín N, Lorenzo M, López D, Perera-Bel J, Rodriguez-Vida A, Fumadó L, Cecchini L, Bellmunt J, Lloreta-Trull J, Hernández-Llodrà S. Segalés L, et al. Among authors: hernandez llodra s. Virchows Arch. 2024 Aug;485(2):281-290. doi: 10.1007/s00428-023-03699-z. Epub 2023 Nov 28. Virchows Arch. 2024. PMID: 38017230 Free PMC article.
12 results